Orion Health Announces Global Launch of Amadeus Accelerates Move to Precision Medicine

Orion HealthOrion Health, the global technology company at the forefront of the revolution in healthcare, is firing up its offering by launching Amadeus, a platform that will enable highly personalised healthcare and the implementation of Precision Medicine.

CEO Ian McCrae says Amadeus is at the forefront of Precision Medicine - the newest frontier in modern healthcare.

"Precision Medicine is enabled when all information unique to an individual is combined to identify preventative care and treatments which will be effective for them based on genetic, environmental and lifestyle factors," says Mr McCrae.

"Today many factors impact health outcomes, yet currently, only a few will be taken into account when healthcare decisions are being made. Amadeus will enable doctors to get the insights they need to help them make accurate diagnoses and provide the optimal treatment," he says.

"In addition, patients will increasingly have the information they need to be active participants in their own healthcare."

Amadeus is a secure open-data platform that scales to aggregate and manage different types of health-related data. Orion Health has evolved its industry-leading population health management platform to accommodate huge data file sizes, including genomic (the genetic makeup of the patient) information.

"What is particularly exciting is that we are delivering Amadeus as an open platform, upon which third parties can innovate. The platform's APIs (Application Program Interfaces) will enable third-party applications to have access to rich data and services so that they can provide additional services that will benefit both doctors and their patients," says Mr McCrae.

Patient privacy is of paramount importance, which is why Amadeus features an advanced privacy service that provides granular access to data elements based on user roles and the sensitivity of the data.

EVP EMEA Wayne Oxenham believes that Precision Medicine will dramatically change healthcare as we know it today.

"Current models of care delivery focus on applying treatments to conditions, not individuals. The consequence of that "one size fits all" approach is that individuals don’t receive treatments that take into account factors that make them unique - their family and clinical history, environmental and social factors, and importantly their genome, which when combined with their clinical information can reveal treatment and prevention strategies right for them," says Oxenham.

Amadeus combines Orion Health’s extensive data integration experience with the scalability and performance of its modern technologies Cassandra™, Spark™ and ElasticSearch™. It has a distributed architecture to handle massive volumes of high velocity data.

The modern data platform incorporates predictive modelling to identify the most at-risk patients in a population to drive rapid decision-making, and will leverage machine-learning to make predictions on its immense data.

Orion Health is already making strides into Precision Medicine and last week joined up with fellow New Zealand medical technology company Medtech and Computer Sciences Corporation (CSC) to work together to deliver a world-leading Precision Medicine solution for New Zealand.

McCrae says that Amadeus goes beyond delivering the technology for today's integrated care and population health management needs - it future-proofs organisations for emerging models of care.

"This is a critical evolution of our business, and for healthcare generally. Imagine a world where everyone receives the treatment that’s perfect for them. That's what we’re aiming for," says Mr McCrae.

Related news articles:

About Orion Health
Orion Health's open technology platform seamlessly integrates all forms of health and relevant personal data to deliver population health and precision medicine solutions across the entire health community. Our solutions enable care for over 90 million patients in more than 30 countries across North America, EMEA and APAC. We have been recognized as the leading vendor by Chilmark and IDC through our leading vision and commitment to continual innovation.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...